A Milestone Moment: FDA Approves Addyi® for Hypoactive Sexual Desire Disorder in Postmenopausal Women
December 17, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Apresoline
Synonyms :
hydralazine
Class :
Vasodilators
Brand Name :
Apresoline
Synonyms :
hydralazine
Class :
Vasodilators
Dosage Forms & Strengths
Injectable solution
20mg/ml
Tablets
10 mg
25 mg
50 mg
100 mg
Take a dose of 10 mg orally every 6 hours for 2 to 4 days; also take a dose of 25 mg every 6 hours daily for the initial week
Then raise dose up to 50 mg every 6 hour from next week
Administer a dose of 20 to 40 mg intramuscularly or intravenously and repeat as required
Administer a dose of 10 to 40 mg intramuscularly or intravenously and dose should not be more than 20 mg
Repeat as required
Associated with Pregnancy
Administer dose of 0.5 to 10 mg/hr as intravenous infusion
Congestive Heart Failure (CHF)
Take initial dose of 10 to 25 mg orally every 6 to 8 hours and titrate dose every 2 to 4 weeks
Take maintenance dose of 225 to 300 mg daily orally divided every 6 to 8 hour
Dosing considerations
Adjust dose according to individual response
Dosage Forms & Strengths
Injectable solution
20mg/ml
Tablets
10 mg
25 mg
50 mg
100 mg
Administer dose of 1.7 to 3.5 mg/kg daily intramuscularly or intravenously divided in 4 to 6 doses
Congestive Heart Failure (CHF)
For Infants:
Administer dose of 0.1 to 0.5 mg/kg intravenously every 6 to 8 hours and dose should not be more than 2 mg/kg
For Children and adolescents:
Administer dose of 0.15 to 0.2 mg/kg intravenously every 4 to 6 hours and dose should not be more than 20 mg
For oral administration
Infants and older:
Administer dose of 0.75 to 3 mg/kg daily orally divided every 6 to 12 hours and daily dose should not be more than 200 mg
For Infants or older:
Administer dose of 0.1 to 0.2 mg/kg intravenously or intramuscularly every 4 to 6 hours initially ass needed; it may raise to usual dose of 1.7 to 3.5 mg/kg daily divided every 4 to 6 hours
Dose should not be more than 20 mg intramuscularly
Refer to adult dosing
may decrease the antihypertensive effect when combined with hydralazine
may decrease the antihypertensive effect when combined with hydralazine
may decrease the antihypertensive effect when combined with hydralazine
may decrease the antihypertensive effect when combined with hydralazine
may decrease the antihypertensive effect when combined with hydralazine
It may enhance the toxicity when combined with mipomersen
it may diminish the excretion rate when combined with permethrin, resulting in an enhanced serum level
It may diminish the metabolism when combined with Vasodilators
It may diminish the metabolism when combined with Vasodilators
It may diminish the metabolism when combined with Vasodilators
It may diminish the metabolism when combined with Vasodilators
It may diminish the metabolism when combined with Vasodilators
It may diminish the metabolism when combined with Vasodilators
When alprazolam and hydralazine is used together, this leads to reduction in the alprazolam’s metabolism
hydralazine: they may decrease the antihypertensive effect of antihypertensive agents
hydralazine: they may decrease the antihypertensive effect of antihypertensive agents
hydralazine: they may decrease the antihypertensive effect of antihypertensive agents
hydralazine: they may decrease the antihypertensive effect of antihypertensive agents
hydralazine: they may decrease the antihypertensive effect of antihypertensive agents
when both drugs are combined, there may be a reduced metabolism of etoposide
when both drugs are combined, there may be a decreased metabolism of vinblastine
May enhances the effects of the other by pharmacodynamic synergism
may enhance the effects of the other by pharmacodynamic synergism
may increase the vasodilatory effect
may increase the vasodilatory effect
may increase the vasodilatory effect
may increase the vasodilatory effect
may increase the vasodilatory effect
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
It may enhance the serum concentration when combined with CYP3A4 Substrates
Actions and Spectrum
The mechanism of action of hydralazine involves the relaxation of the smooth muscles in the walls of arterioles. By relaxing these blood vessels, hydralazine reduces peripheral resistance, which leads to a decrease in blood pressure.
Frequency not defined
Hypotension
Tachycardia
Peripheral edema
Paralytic ileus
Arthralgia
SLE syndrome
Thrombocytopenia
Anorexia
Dysurea
Chest pain
Diarrhea
Rheumatoid arthritis
Agranulocytosis
Hepatotoxicity
Peripheral neuritis
Agranulocytosis
Psychotic reaction
Dyspnea
Nasal congestion
Leukopenia
Headache
Vascular collapse
Nausea
Vomiting
Peripheral neuropathy
Palpitations
Conjunctivitis
Black Box Warning
None
Contraindication/Caution:
Contraindication:
Caution:
Pregnancy consideration:
Pregnancy category: C
Lactation: Excretion into human milk is known
Pregnancy Categories:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
hydralazine is a direct-acting vasodilator medication with antihypertensive properties.
It causes vasodilation and a decrease in peripheral resistance by relaxing the smooth muscles that line the walls of arterioles.
Pharmacodynamics
The smooth muscles of the arterioles are the main target of the powerful arterial vasodilator hydralazine. The vascular smooth muscle is directly relaxed, which causes the arteries to enlarge.
As a result of this dilatation, systemic vascular resistance is decreased, and blood pressure is lowered.
Pharmacokinetics
Absorption
hydralazine is absorbed after oral administration.
Distribution
hydralazine distributes throughout the body tissues. It is bound to plasma proteins, with approximately 87% to 90% bound to albumin.
Metabolism
hydralazine undergoes metabolism in the liver, primarily through acetylation.
Elimination and excretion
The elimination of hydralazine and its metabolites occurs primarily through the kidneys. The elimination half-life ranges from 2 to 7 hours.
Administration
hydralazine is available in various formulations, including tablets and injectable solutions.
Patient information leaflet
Generic Name: hydralazine
Why do we use hydralazine?
hydralazine is an effective medication for lowering blood pressure.
hydralazine helps relax and dilate the arterioles, reducing peripheral resistance and lowering blood pressure.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
